Furthermore, in both mouse models of MDS and primary samples, Muto et al. observed that MDS HSPCs exhibited a preferential activation of the noncanonical NF-κB pathway which protects these cells from chronic inflammation, while normal HSPCs exhibited activation of canonical NF-κB signaling [59]. The gene discussed is NFKB1; the disease is myelodysplastic syndrome.